Stocks and Investing Stocks and Investing
Wed, February 28, 2018
Tue, February 27, 2018
Mon, February 26, 2018
Fri, February 23, 2018
Thu, February 22, 2018
Wed, February 21, 2018

Paul Matteis Maintained (WVE) at Buy with Increased Target to $64 on, Feb 21st, 2018


Published on 2024-10-26 03:07:08 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Leerink Swann, Maintained "Wave Life Sciences Ltd." (WVE) at Buy with Increased Target from $53 to $64 on, Feb 21st, 2018.

Paul, nor any peers, have made any analyst calls on WVE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30